Programme Vitiligo International Symposium

The conferences is intended to foster discussion and exchange of individual experience in the approach to Vitiligo. Thus, the 12 minutes talks are splitted into 7 minutes focused presentation and 5 minutes discussion.

2 December

  • 08.30 - 09.00 - Welcome with coffee / Installation of posters
  • 09.00 - 09.15 - Introduction by the Chairs Mauro Picardo and Alain Taieb: Facing challenges in vitiligo research
  • 09.15 - 09.45 - Introductory lecture presented by Harvey Lui
    Richard Spritz: Key pathways identified by genetic studies

♦ 09.45 - 11.40 - Session 1 – New insights from basic and translational research

  • 09.45 - 10.00 - Introduction by John Harris
  • 10.00 - 11.30 - Oral presentations chosen from submitted abstracts:

                                > Jacquemin Clément, Manga Prashiela, Harris John, Kovacs Daniela
                                > Dell’Anna Maria Lucia, Bordignon Matteo, Suzuki Tamio

  • 11.30 - 11.40 - Conclusions by Hee Young Kang
  • 11.40 - 12.00 - Coffee break + poster viewing
  • 12.00 - 12.30 - Invited lecture presented by Leihong Flora Xiang
    Ralf Paus: Hair follicle melanocytes and their stem cells as a repigmentation resource
  • 12.30 - 12.45 - Rome San Gallicano workshop II on outcome measures: preliminary data (Alain Taieb, Nanja Van Geel, Reinhart Speeckaert, Viktoria Eleftheriadou, Mauro Picardo)
  • 12.45 - 14.00 - Lunch

♦ 14.00 - 16.10 - Session 2 – Outcome research part 1: Prognosis/biomarkers

  • 14.00 - 14.15 - Introduction by Amit Pandya
  • 14.15 - 16.00 - Oral presentations chosen from submitted abstracts:

                                > Speeckaert Reinhart, Abdallah Marwa Hinojosa Jorge, Harris John, Boniface Katia
                                > Yang Lingli, Kaushik Hitaishi, Piquero-Casals Jaime

  • 16.00 - 16.10 - Conclusions by Nanja Van Geel and Reinhart Speeckaert
  • Luigi Naldi)16.10 - 17.15 - Coffee break + Poster walk 1 (Leaders: Lionel Larue, Samia Esmat,

♦ 17.00 - 18.40 -Session 3 - Outcome research part 2: Assessment/scoring

  • 17.10 - 18.55 - Introduction by Iltefat Hamzavi
  • 17.30 - 18.45 - Oral presentations chosen from submitted abstracts:

                                > Van Geel Nanja, Coias Jennifer, Jung Min Bae, Shalaby Suzan,  Wright Evan J

  • 18.45 - 18.55 - Conclusions by Khaled Ezzedine
  • 18.55 - 19.15 - General discussion led by Mauro Picardo and Alain Taieb
  • 20.00 - 22.00 - Social Event

3 December

  • 08.30 - 09.00 - Welcome with coffee
  • 09.00 - 09.10 - Update by the Chairs Mauro Picardo and Alain Taieb
  • 09.10 - 09.40 - Invited lecture presented by Pearl Grimes
    Caroline Le Poole: New perspectives in vitiligo therapies

♦ 09.40 -11.40 - Session 4 - Management of vitiligo: combining physicians’ and patients’ perspectives

  • 09.40 - 09.55 - Introduction by Davinder Parsad
  • 09.55 - 11.35 - Oral presentations chosen from submitted abstracts:

                                > Anbar Tag, Cestari Tania, Van Geel Nanja, Alissa Ahmed
                                > Eid Amira, Speeckaert Reinhart, Debdeep Mitra, Debdeep Mitra

  • 11.35 - 11.45 - Conclusions by Debdeep Mitra
  • 11.45 - 12.00 - Coffee break + poster view
  • 12.00 - 12.30 - Invited lecture presented by Ichiro Katayama
    Eddy Hsi Chun Wang (Columbia University Medical Center of New York) Treatment with JAK inhibitors: prevention and reversal of clinical manifestations.
  • 12.30 - 13.45 - Lunch

♦ 13.45 - 15.50 - Session 5 - Clinical and experimental studies

  • 13.45 - 14.00  - Introduction by Thierry Passeron
  • 14.00 - 15.40  - Oral presentations chosen from submitted abstracts:

                                 > Erf Gisela, Ichihashi Masamitsu, Kotobuki Yorihisa, Raboobee Noufal
                                 > Benzekri Laila, Lommerts Annelies, Seneschal Julien, Lui Harvey

  • 15.40 - 15.50 - Conclusions by Bon Kee Goh
  • 15.50 - 17.00 - Coffee break + Poster walk 2 (Leaders: Laila Benzekri, Tamio Suzuki, Silvia Moretti, Prasad Kumarasinghe)

♦ 17.00 - 18.20 - Session 6 - New therapeutic targets

  • 17.00 - 17.10 - Introduction by Julien Seneschal
  • 17.10 - 18.10 - Oral presentations chosen from submitted abstracts

                                > Harris John, EL-Hawary Marwa, Van Geel Nanja, Babino Graziella, Pacifico Alessia

  • 18.10 - 18.20  - Conclusions by Eric Lan and Giovanni Leone

♦ 18.20 – 19.30 - Session 7 – Clinical reports

  • 18.20 - 18.30 - Introduction by Agustin Alomar
  • 18.30 - 19.20  - Oral presentations chosen from submitted abstracts:

                                 > Castro Caio, Katayama Ichiro, Gupta Monisha, Anbar Tag

  • 19.20 - 19.30 - Conclusions by Henry Lim
  • 19.30 - 20.00 - General discussion and concluding remarks by Mauro Picardo and Alain Taieb
  • 20.00 - Aperitif and closing party

 download program

 

WITH THE UNCONDITIONED CONTRIBUTION OF